Ademetionine

Ademetionine

SCHEMBL55479

C[S+](CCC(N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 5/20 1.00
AMD1 P17707 4/20 1.00
PCMT1 P22061 3/20 0.87
PRMT5 O14744 3/20 0.87
PRMT1 Q99873 3/20 0.87
NSD3 Q9BZ95 2/20 0.87
PRMT3 O60678 2/20 0.87
PNMT P11086 2/20 0.87
PRMT6 Q96LA8 2/20 0.87
WDR77 Q9BQA1 2/20 0.87
PRMT7 Q9NVM4 2/20 0.87
ADORA3 P0DMS8 1/20 0.87
KDR P35968 1/20 0.87
PRMT8 Q9NR22 1/20 0.87
NNMT P40261 3/20 0.72
DOT1L Q8TEK3 5/20 0.71
NSD2 O96028 3/20 0.71
SETD7 Q8WTS6 3/20 0.71
EHMT2 Q96KQ7 3/20 0.71
TRDMT1 O14717 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ademetionine SCHEMBL13033865 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL600368 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL66767 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL2007787 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL599664 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL4164615 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL7810282 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL59293 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL3202538 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1
Ademetionine SCHEMBL9518716 1.00 CARM1 (1.00) CARM1AMD1PCMT1PRMT5PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7474 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087508-A1 HYDROGELS CONTAINING COVALENTLY LINKED COFACTORS AND METHODS FOR PREPARING THE SAME HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2026-04-30 WO claimed
US-20260062439-A1 Enzymatic RNA Capping Method NEW ENGLAND BIOLABS, INC. (US) 2026-03-05 US claimed
WO-2026047150-A1 CYCLOPROPANE-TAGGING METHOD FOR TRACKING FATTY ACID TRANSPORT BETWEEN CELLS AND TISSUES IN VIVO AND IN CELL CULTURE THE FRANCIS CRICK INSTITUTE LIMITED (GB) 2026-03-05 WO claimed
US-20260062438-A1 Enzymatic RNA Capping Method NEW ENGLAND BIOLABS, INC. (US) 2026-03-05 US claimed
EP-4698567-A1 HYDROGELS CONTAINING COVALENTLY LINKED COFACTORS AND METHODS FOR PREPARING THE SAME Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2026-02-25 EP claimed
US-20260015379-A1 Enzymatic RNA Capping Method NEW ENGLAND BIOLABS, INC. (US) 2026-01-15 US claimed
US-20260015677-A1 METHYLATION METHOD SYNDEX BIO LTD (GB) 2026-01-15 US claimed
EP-4673539-A1 GENETICALLY MODIFIED MICROORGANISM AND FERMENTATION PROCESS FOR THE PRODUCTION OF D-ALLULOSE Cargill, Incorporated (US) 2026-01-07 EP claimed
US-20250388618-A1 Enzymatic RNA Capping Method NEW ENGLAND BIOLABS, INC. (US) 2025-12-25 US claimed
US-12479880-B2 Enzymatic RNA capping method NEW ENGLAND BIOLABS, INC. (US) 2025-11-25 US claimed
US-5885976-A Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions SANDYK REUVEN (US) 1999-03-23 US claimed
EP-0844890-A1 THE USE OF BILE ACID DERIVATIVES THE UNIVERSITY OF BIRMINGHAM (GB) 1998-06-03 EP claimed
WO-1997006829-A1 THE USE OF BILE ACID DERIVATIVES THE UNIVERSITY OF BIRMINGHAM (GB) 1997-02-27 WO claimed
WO-1996037780-A1 COMPOSITIONS AND METHODS FOR DETECTING SCHIZOPHRENIA DETH RICHARD C (US) 1996-11-28 WO claimed
EP-0516660-B1 USE OF S-ADENOSYL METHIONINE AS AN AGENT AGAINST VIRAL INFECTIONS BY RETROVIRUSES Grundmann, Ewald, Dr. (DE) 1993-08-18 EP claimed
EP-0528452-A1 Immunomycin enzymatic and/or microbial methylation products MERCK & CO. INC. (US) 1993-02-24 EP claimed
EP-0387757-A2 Use of 5'-deoxy-5'methylthioadenosine, S-adenosylmethionine and their salts in the preparation of pharmaceutical compositions favouring hair growth in subjects suffering from baldness BIORESEARCH S.p.A. (IT) 1990-09-19 EP claimed
EP-0387756-A1 Use of 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions BIORESEARCH S.p.A. (IT) 1990-09-19 EP claimed
US-4957757-A Method of extending shelf life and enhancing keeping quality of fruits CORNELL RESEARCH FOUNDATION, INC. (US) 1990-09-18 US claimed
US-4562149-A CULTIVATING A MICROORGANISM IN LIQUID CULTURE MEDIUM CONTAINING METHIONINE NIPPON ZEON CO., LTD. (JP) 1985-12-31 US claimed